Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

A thorough skin history and examination are essential for diagnosing and treating skin conditions effectively.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Multi-pass laser skin treatments improved healing, reduced pain, and had no major complications.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

The DLQI is a key tool for measuring quality of life in dermatology.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

Elderly abuse is often by family members, and doctors, especially dermatologists, can spot it by looking for unusual injuries and malnutrition.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Platelet-rich plasma (PRP) shows promise for treating melasma but needs more research for confirmation.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Both rosemary extract and 2% ketoconazole lotions effectively treat seborrheic dermatitis and improve quality of life.

Botulinum toxin type A effectively reduces pain in hair loss disorders.

The polynucleotide-based gel effectively treats hair loss with minimal side effects.